Impact of BCL3 Expression and Clinical-Hematologic Risk Factors on Early Molecular Response, Reticulin Fibrosis, and Survival Outcomes in Chronic Myeloid Leukemia: A Prognostic Cohort Study.

Shalaby N, Fouda MA, Fawzy EMM, Elagooz R, El-Seaidy MAAEA, Aladl HAA, Abdelhady DA, Farrag Z, Shahin GN, Hassan MM, Elshafey OHA, Elsayed FM, Hegazy HA, Alwaseef MAE, Akef A

Open source

DOI
10.7417/ct.2026.2169
Published
2026 Nov-Dec
Container
La Clinica terapeutica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7417/ct.2026.2169,
  title = {Impact of BCL3 Expression and Clinical-Hematologic Risk Factors on Early Molecular Response, Reticulin Fibrosis, and Survival Outcomes in Chronic Myeloid Leukemia: A Prognostic Cohort Study.},
  author = {Shalaby N and Fouda MA and Fawzy EMM and Elagooz R and El-Seaidy MAAEA and Aladl HAA and Abdelhady DA and Farrag Z and Shahin GN and Hassan MM and Elshafey OHA and Elsayed FM and Hegazy HA and Alwaseef MAE and Akef A},
  year = {2026},
  journal = {La Clinica terapeutica},
  doi = {10.7417/ct.2026.2169},
  url = {https://doi.org/10.7417/ct.2026.2169}
}

RIS

TY  - JOUR
TI  - Impact of BCL3 Expression and Clinical-Hematologic Risk Factors on Early Molecular Response, Reticulin Fibrosis, and Survival Outcomes in Chronic Myeloid Leukemia: A Prognostic Cohort Study.
AU  - Shalaby N
AU  - Fouda MA
AU  - Fawzy EMM
AU  - Elagooz R
AU  - El-Seaidy MAAEA
AU  - Aladl HAA
AU  - Abdelhady DA
AU  - Farrag Z
AU  - Shahin GN
AU  - Hassan MM
AU  - Elshafey OHA
AU  - Elsayed FM
AU  - Hegazy HA
AU  - Alwaseef MAE
AU  - Akef A
PY  - 2026
JO  - La Clinica terapeutica
DO  - 10.7417/ct.2026.2169
UR  - https://doi.org/10.7417/ct.2026.2169
ER  - 

APA

N, S., MA, F., EMM, F., R, E., MAAEA, E., HAA, A., DA, A., Z, F., GN, S., MM, H., OHA, E., FM, E., HA, H., MAE, A., & A, A. (2026). Impact of BCL3 Expression and Clinical-Hematologic Risk Factors on Early Molecular Response, Reticulin Fibrosis, and Survival Outcomes in Chronic Myeloid Leukemia: A Prognostic Cohort Study.. La Clinica terapeutica. https://doi.org/10.7417/ct.2026.2169

Source records